全球唯一！国产长效镇痛新药在美国获批上市


散仙谷 http://www.webjb.org/webjb/sanxian/


送交者: testtesttest 于 2025-06-05 01:25:22


2025-05-16
5 月 16 日，中国生物制药宣布，其与清普生物达成合作的非阿片类镇痛新药美洛昔康注射液（II）除了获得中国 NMPA 批准外（中国商品名：普坦宁），也在近期获得美国 FDA 批准（美国商品名：QAMZOVA）上市。
https://www.163.com/dy/article/JVMTGUO80532CO9S.html

------------------
英文报道
US: FDA greenlights China\'s 1st painkiller to combat fentanyl overdoses
Akash Pandey
May 24, 2025
The US Food and Drug Administration (FDA) has approved Qamzova, a groundbreaking painkiller created by Delova, a biotech company based in Nanjing, China.
The non-opioid drug is intended to help curb deaths due to fentanyl overdoses.
Qamzova is the world\'s first long-acting injectable analgesic that provides 24-hour pain relief with a single daily injection.

Qamzova: A new player in pain management
Qamzova falls under the category of non-steroidal anti-inflammatory (NSAID) drugs, much like popular painkillers such as aspirin and ibuprofen.

However, it contains a much higher dose of meloxicam, a component commonly used to alleviate inflammation and pain.

Clinical trials, according to Sino Biopharmaceutical, the Chinese company that holds commercial rights to Qamzova, have shown its ability to reduce opioid consumption after surgery.

Potential solution to the US overdose crisis
Qamzova provides a safer, long-lasting treatment option for moderate to severe pain, directly tackling the US overdose crisis fueled by addictive opioids like fentanyl.

Fentanyl is a synthetic drug linked to tens of thousands of annual deaths.

The launch of Qamzova underscores China\'s increasing role in the development of innovative medicine and gives healthcare professionals a critical tool to minimize opioid dependence and improve patient recovery.
https://www.newsbytesapp.com/news/science/us-approves-china-made-painkiller-that-may-reduce-fentanyl-overdoses/story

阅读次数：179

所有跟贴:

加跟贴

笔名: 密码: 注册笔名请按这里
标题:   分类主题名:

内容(可选项):

URL(可选项):
URL标题(可选项):
图像(可选项): 图片上传工具


所有跟贴·加跟贴·ɢɹ
Copyright © 2000 - 2020 webjb.org